254 related articles for article (PubMed ID: 8175472)
21. Serum thyroxine and triiodothyronine concentrations in canine pyoderma.
Slade EA; Thompson FN; Lorenz MD; Kemppainen RJ
J Am Vet Med Assoc; 1984 Jul; 185(2):216-8. PubMed ID: 6746394
[TBL] [Abstract][Full Text] [Related]
22. Primary hypoparathyroidism in dogs: a retrospective study of 17 cases.
Russell NJ; Bond KA; Robertson ID; Parry BW; Irwin PJ
Aust Vet J; 2006 Aug; 84(8):285-90. PubMed ID: 16911229
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of risk factors for fatal acute pancreatitis in dogs.
Hess RS; Kass PH; Shofer FS; Van Winkle TJ; Washabau RJ
J Am Vet Med Assoc; 1999 Jan; 214(1):46-51. PubMed ID: 9887939
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of and intrinsic risk factors for appendicular osteosarcoma in dogs: 179 cases (1996-2005).
Rosenberger JA; Pablo NV; Crawford PC
J Am Vet Med Assoc; 2007 Oct; 231(7):1076-80. PubMed ID: 17916033
[TBL] [Abstract][Full Text] [Related]
25. [Total thyroxine (T4) and free thyroxine (FT4) in hypothyroidism and nonthyroid diseases of dogs].
Kraft W; Dietl A
Tierarztl Prax; 1994 Oct; 22(5):472-9. PubMed ID: 7855856
[TBL] [Abstract][Full Text] [Related]
26. Effects of phenobarbital treatment on serum thyroxine and thyroid-stimulating hormone concentrations in epileptic dogs.
Gaskill CL; Burton SA; Gelens HC; Ihle SL; Miller JB; Shaw DH; Brimacombe MB; Cribb AE
J Am Vet Med Assoc; 1999 Aug; 215(4):489-96. PubMed ID: 10461631
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for development of chronic superficial keratitis in dogs.
Chavkin MJ; Roberts SM; Salman MD; Severin GA; Scholten NJ
J Am Vet Med Assoc; 1994 May; 204(10):1630-4. PubMed ID: 8050943
[TBL] [Abstract][Full Text] [Related]
28. [Clinical, hematological, biochemical and endocrinological aspects of 32 dogs with hypothyroidism].
Boretti FS; Breyer-Haube I; Kaspers B; Reusch CE
Schweiz Arch Tierheilkd; 2003 Apr; 145(4):149-56, 158-9. PubMed ID: 12741092
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of intestinal nematode parasitism among pet dogs in the United States (2003-2006).
Mohamed AS; Moore GE; Glickman LT
J Am Vet Med Assoc; 2009 Mar; 234(5):631-7. PubMed ID: 19250042
[TBL] [Abstract][Full Text] [Related]
30. Replacement therapy for induced hypothyroidism in dogs.
Hightower D; Kyzar JR; Chester DK; Wright EM
J Am Vet Med Assoc; 1973 Oct; 163(8):979-80. PubMed ID: 4796094
[No Abstract] [Full Text] [Related]
31. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
32. Hypothyroid-associated central vestibular disease in 10 dogs: 1999-2005.
Higgins MA; Rossmeisl JH; Panciera DL
J Vet Intern Med; 2006; 20(6):1363-9. PubMed ID: 17186851
[TBL] [Abstract][Full Text] [Related]
33. Canine hypothyroidism.
Chastain CB
J Am Vet Med Assoc; 1982 Aug; 181(4):349-53. PubMed ID: 6749781
[No Abstract] [Full Text] [Related]
34. Prevalence of autoantibodies to thyroglobulin in dogs with nonthyroidal illness.
Nachreiner RF; Refsal KR; Graham PA; Hauptman J; Watson GL
Am J Vet Res; 1998 Aug; 59(8):951-5. PubMed ID: 9706197
[TBL] [Abstract][Full Text] [Related]
35. Clinical and pathologic findings in dogs with atherosclerosis: 21 cases (1970-1983).
Liu SK; Tilley LP; Tappe JP; Fox PR
J Am Vet Med Assoc; 1986 Jul; 189(2):227-32. PubMed ID: 3744984
[TBL] [Abstract][Full Text] [Related]
36. Epidemiological, clinical, haematological and biochemical characteristics of canine hypothyroidism.
Dixon RM; Reid SW; Mooney CT
Vet Rec; 1999 Oct; 145(17):481-7. PubMed ID: 10596870
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of diagnostic characteristics indicating canine autoimmune lymphocytic thyroiditis in giant schnauzer and hovawart dogs.
Ferm K; Björnerfeldt S; Karlsson A; Andersson G; Nachreiner R; Hedhammar A
J Small Anim Pract; 2009 Apr; 50(4):176-9. PubMed ID: 19320811
[TBL] [Abstract][Full Text] [Related]
38. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
39. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
40. Functional and morphological changes in the adenohypophysis of dogs with induced primary hypothyroidism: loss of TSH hypersecretion, hypersomatotropism, hypoprolactinemia, and pituitary enlargement with transdifferentiation.
Diaz-Espiñeira MM; Mol JA; van den Ingh TS; van der Vlugt-Meijer RH; Rijnberk A; Kooistra HS
Domest Anim Endocrinol; 2008 Jul; 35(1):98-111. PubMed ID: 18400449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
